of dental dental procedures use needles.
of all people feel uneasy or are concerned about the idea of oral needles.
of patients feel oral pain during their dental treatment.
miss or delay dental appointments due to anxiety.
of dentists are constantly stressed and burnt out at their workplace.
Unfortunately, fear of pain leads to fewer visits to the dental office and more last-minute cancellations, which only complicate oral health issues and make it more difficult and expensive to treat. A vicious cycle is consequently formed.
During a casual chat in 2015, Omar Zuaiter (a dentist) and Alaa Habeb (an engineer) marvelled at the conundrum that almost everything in the dental clinic seems to exude anxiety by design, from terrifying needles to noisy drills to suffocating sprays and pain.
In response, Omar and Alaa launched Dentroid in 2017 to pioneer a distinctive human-centric rather than tooth-centric approach.
Guided by this founding principle, Dentroid has been harnessing the synergetic power of photonics and robotics and developing new technologies that will replace needles, drills and sprays to unleash the full potential of dentistry for patients and dentists alike.
Inventors Dr. Omar Zuaiter and Mr. Alaa Habeb submit patent application for Dentroid-R.
Dentroid is incorporated as Emudent Technologies.
Dentroid wins a competitive pre-seed funding and acceleration from Canberra Innovation Network.
Dentroid is a finalist in the "Best Idea" category of Talent Unleashed Awards.
The world's first remote simulation dental cavity is successfully prepared using the using Dentroid-R rotary prototype.
Australian Federal Health Minister Mr Greg Hunt visits Dentroid.
Dentroid receives a grant from the Australian Capital Territory Government.
Dentroid completes an oversubscribed seed round.
Dentroid is a semi-finalist in the Australian Technologies Competition 2018.
Dentroid receives a grant by the Advanced Manufacturing Growth Centre (AMGC).
Dentroid presents its first laser enabled robotic prototype.
Dentroid receives ARC Grant (Australian Research Council).
Dentroid publishes in several peer-reviewed journals and presents at key conferences.
Dentroid submits the second patent family for Nuralyte, the needle-free analgesia / anaesthesia.
Patents for Dentroid-R are granted across the US, Canada, Australia, South Africa, France, Italy, Spain, China, India, Brazil, South Korea, Germany, UK, Japan and Switzerland
Dentroid conducts 5 successful clinical trials for Nuralyte.
Dentroid receives AEA Grant (Australia’s Economic Accelerator).
Patent for Nuralyte is granted in Australia.
NuralyteTM Stage 2 clinical trials begin involving 900+ patients.
Dentroid won ACT Chief Minister’s Emerging Exporter Award2025, progressing as national finalists in the 63rd AustralianExport Awards.
Our mission is to make dentistry a gentler and more efficient experience for patients and dentists by replacing manual treatment with ultra-precise automation and robotic solutions.
Innovate Boldly
We believe in pushing the boundaries of dental technology through innovation and pioneering photonic solutions to redefine pain-free dentistry.
Impact Dentistry
We aim to transform dentistry to impact lives positively and are committed to making meaningful changes in dental healthcare.
Collaborative Trust
We value genuine partnerships and understand the transformative impact they can have when working together.
